Cyclin-Dependent Kinase Inhibitor p18
"Cyclin-Dependent Kinase Inhibitor p18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.
| Descriptor ID |
D050763
|
| MeSH Number(s) |
D12.644.360.225.300 D12.776.167.187.300 D12.776.476.225.300 D12.776.624.776.355.300
|
| Concept/Terms |
Cyclin-Dependent Kinase Inhibitor p18- Cyclin-Dependent Kinase Inhibitor p18
- Cyclin Dependent Kinase Inhibitor p18
- p18 CDK6 Inhibitor
- CDK6 Inhibitor, p18
- CDK6-Associated Protein p18
- CDK6 Associated Protein p18
- p18, CDK6-Associated Protein
- p18INK4c Protein
- Cyclin-Dependent Kinase Inhibitor 2C
- Cyclin Dependent Kinase Inhibitor 2C
- INK4C Protein
- CDKN2C Protein
|
Below are MeSH descriptors whose meaning is more general than "Cyclin-Dependent Kinase Inhibitor p18".
Below are MeSH descriptors whose meaning is more specific than "Cyclin-Dependent Kinase Inhibitor p18".
This graph shows the total number of publications written about "Cyclin-Dependent Kinase Inhibitor p18" by people in this website by year, and whether "Cyclin-Dependent Kinase Inhibitor p18" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclin-Dependent Kinase Inhibitor p18" by people in Profiles.
-
Robinson DR, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, Cao X, Rabban E, Kumar-Sinha C, Raymond V, Schuetze S, Alva A, Siddiqui J, Chugh R, Worden F, Zalupski MM, Innis J, Mody RJ, Tomlins SA, Lucas D, Baker LH, Ramnath N, Schott AF, Hayes DF, Vijai J, Offit K, Stoffel EM, Roberts JS, Smith DC, Kunju LP, Talpaz M, Cieslik M, Chinnaiyan AM. Integrative clinical genomics of metastatic cancer. Nature. 2017 08 17; 548(7667):297-303.
-
Barrett MT, Deiotte R, Lenkiewicz E, Malasi S, Holley T, Evers L, Posner RG, Jones T, Han H, Sausen M, Velculescu VE, Drebin J, O'Dwyer P, Jameson G, Ramanathan RK, Von Hoff DD. Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. Br J Cancer. 2017 Aug 08; 117(4):572-582.
-
Chae YK, Davis AA, Carneiro BA, Chandra S, Mohindra N, Kalyan A, Kaplan J, Matsangou M, Pai S, Costa R, Jovanovic B, Cristofanilli M, Platanias LC, Giles FJ. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA. Oncotarget. 2016 Oct 04; 7(40):65364-65373.
-
Zindy F, Nilsson LM, Nguyen L, Meunier C, Smeyne RJ, Rehg JE, Eberhart C, Sherr CJ, Roussel MF. Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice. Cancer Res. 2003 Sep 1; 63(17):5420-7.
-
Watanabe G, Pena P, Shambaugh GE, Haines GK, Pestell RG. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development. Brain Res Dev Brain Res. 1998 Jun 15; 108(1-2):77-87.